glp-1 litigation news today GLP-1s: Litigation, Enforcement, and Marketing Watchpoints Novo Nordisk Seeks Injunction Against

Marketing glutathione specifically for skin lightening or whitening is illegal in the United States under FDA cosmetic and drug regulations

The substance's supposed benefits are largely based on anecdotal evidence, and the interest in it appears to be driven by those who stand to benefit from increased demand, said Nina Zeldes, a researcher at Public Citizen's Health Research Group, a nonprofit watchdog group, in testimony on the morning of July 23 opposing the inclusion of BPC-157

2025 Forbes Best-in-State Wealth Management Teams: Awarded January 2025

Treatment of this disorder is based upon experience and observation as opposed to an evidence-based treatment regimen